Exercise and Reduced Nicotine Content Cigarettes in Adult Female Smokers: A Pilot Trial.
cardiovascular disease
insulin resistance
obesity
physical activity
smoking cessation
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
29 05 2022
29 05 2022
Historique:
received:
25
03
2022
revised:
24
05
2022
accepted:
27
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Background: Although Reduced Nicotine Cigarettes (RNC) are suggested to improve smoking cessation and cardiometabolic health in relation to cancer risk, the effectiveness of exercise training with RNC on smoking cessation and cardiometabolic health is unknown. Methods: Female smokers (N = 27) were randomized to: (1) usual nicotine cigarettes (i.e., control), (2) RNC or (3) RNC plus exercise treatment for 12 weeks. Smoking withdrawal symptoms (e.g., Wisconsin Smoking Withdrawal Scale) and cardiometabolic health (e.g., weight, VO2max, resting respiratory exchange ratio (RER), glucose, HOMA-IR) were examined before and after treatment. Results: Treatments had no differential effect on weight (p = 0.80; partial η2 = 0.29), VO2max (p = 0.20, partial η2 = 0.18), or total cholesterol/HDL ratios (p = 0.59, partial η2 = 0.06). However, RNC + Exercise tended to maintain RER (i.e., fat oxidation; p = 0.10, partial η2 = 0.10) as well as insulin resistance (p = 0.13, partial η2 = 0.25) and cortisol compared (p = 0.06, partial η2 = 0.30) with control and RNC. Increased VO2max was also associated with lower nicotine dependence scores (r = −0.50, p < 0.05). Conclusion: In this pilot study, improved fitness was associated with lower nicotine dependence. Additional work is warranted to examine the effects of exercise in smokers as a tool to improving smoking cessation and lower disease risk.
Identifiants
pubmed: 35682232
pii: ijerph19116647
doi: 10.3390/ijerph19116647
pmc: PMC9180864
pii:
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR003016
Pays : United States
Références
Obesity (Silver Spring). 2016 Jul;24(7):1515-21
pubmed: 27221649
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):700-9
pubmed: 25573855
N Engl J Med. 2015 Oct;373(14):1340-9
pubmed: 26422724
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L743-L756
pubmed: 29351435
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Exp Clin Psychopharmacol. 1999 Nov;7(4):354-61
pubmed: 10609970
Diabetes. 2012 Dec;61(12):3156-66
pubmed: 22966072
Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1292-8
pubmed: 24064339
N Engl J Med. 2013 Jan 24;368(4):341-50
pubmed: 23343063
Am J Clin Nutr. 1986 Apr;43(4):486-94
pubmed: 3962901
PLoS One. 2016 Apr 25;11(4):e0154063
pubmed: 27111219
J Obes Weight Loss Ther. 2015 Jul;5(Suppl 5):
pubmed: 26523243
Psychopharmacology (Berl). 2012 Jul;222(1):1-15
pubmed: 22585034
Diabetes Care. 2009 Oct;32(10):1807-11
pubmed: 19592624
J Natl Cancer Inst. 2014 Oct 01;106(11):
pubmed: 25274579
Addiction. 2010 Feb;105(2):343-55
pubmed: 20078491
Thorax. 1986 Nov;41(11):886-7
pubmed: 3824275
Hypertension. 2003 Jan;41(1):183-7
pubmed: 12511550
Ann Intern Med. 1993 Nov 15;119(10):992-1000
pubmed: 8214996
Am J Nephrol. 2015;42(4):274-81
pubmed: 26495987
Contemp Clin Trials. 2019 Jan;76:31-40
pubmed: 30445176
N Engl J Med. 1991 Mar 14;324(11):739-45
pubmed: 1997840
Rev Endocr Metab Disord. 2016 Mar;17(1):81-90
pubmed: 27106830
Prev Med. 2014 Oct;67:189-92
pubmed: 25091879
Med Sci Sports Exerc. 2018 Oct;50(10):2058-2066
pubmed: 29762253
Health Psychol. 1996 Nov;15(6):448-54
pubmed: 8973925
Lancet. 1992 May 9;339(8802):1128-30
pubmed: 1349365
BMC Med Res Methodol. 2014 Mar 20;14:41
pubmed: 24650044